Our analysis highlights that ASCETIC consistently identifies alterations in CALR, JAK2, and IDH1/2 genes as early events in tumor history, while NRAS represents an acquired secondary event, towards which evolutionary trajectories appear to converge during the progression of the disease. Here, NRAS is linked to neoplasm.